Investigation of the stool microbiome of short bowel syndrome patients before and after a 24-week treatment with the glucagon-like peptide 2 analog glepaglutide

Authors

Institutions

Publication Details

Journal
Clinical Nutrition ESPEN
Published
2026-02-25
DOI
https://doi.org/10.1016/j.clnesp.2026.102989
Primary Topic
Clinical Nutrition and Gastroenterology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigation of the stool microbiome of short bowel syndrome patients before and after a 24-week treatment with the glucagon-like peptide 2 analog glepaglutide

Ismail Pinar, Mark Hvistendahl, Thorsten Brach, Mark Berner‐Hansen et al.
Clinical Nutrition ESPEN
Clinical Nutrition and Gastroenterology
article

Investigation of the stool microbiome of short bowel syndrome patients before and after a 24-week treatment with the glucagon-like peptide 2 analog glepaglutide

Ismail Pinar, Mark Hvistendahl, Thorsten Brach, Mark Berner‐Hansen, Thor Schütt Svane Nielsen, Bjørn Henrik Nielsen, Janne Marie Moll, Palle B. Jeppesen
article en

Abstract

No abstract available for this paper.
Clinical Nutrition ESPENVol. 73
Statistics Denmark (DK), Bispebjerg Hospital (DK), Rigshospitalet (DK), Zealand Pharma (Denmark) (DK)
Good health and well-being
Openalex Percentile: Top 42%
Clinical Nutrition and Gastroenterology
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.